创伤性脑损伤后慢性疼痛的协同照护:一项随机临床试验
这项随机临床试验在华盛顿州西雅图2家医院附属学术康复医学诊所开展,纳入创伤性脑损伤至少6个月且伴慢性疼痛的成人,比较协同照护(CC,称为TBI Care,16周内最多12次面对面或电话访视,由照护管理者提供以人为中心的认知行为治疗,并每周与专家团队讨论)与常规照护(UC)。共筛查1379人,随机158例(CC 79例、UC 79例);4个月时CC组疼痛干扰评分显著低于UC组(均数[SD] 3.46[2.17] vs 5.03[2.28]),8个月时仍维持(3.61[2.22] vs 4.68[2.51])。4个月时CC组疼痛严重度、抑郁和焦虑症状也显著低于UC组,满意度更高。作者认为CC可有效降低疼痛干扰,并需进一步研究其在其他医疗环境中的实施与成本效果。
要点
- 对TBI后慢性疼痛成人,16周内最多12次协同照护访视(含面对面或电话)在4个月时疼痛干扰评分显著低于常规照护(3.46[2.17] vs 5.03[2.28])。
- 协同照护的疼痛干扰改善维持至随机后8个月(CC 3.61[2.22] vs UC 4.68[2.51])。
- 4个月时CC组疼痛严重度(3.63[1.95] vs 4.90[1.96])、抑郁症状(8.07[5.34] vs 11.31[6.37])和焦虑症状(6.20[5.17] vs 9.58[6.00])均显著低于UC组。
- CC组对疼痛治疗、临床照护和整体医疗的满意度评分显著高于UC组,整体变化印象评分显著更低(2.74[1.02] vs 3.47[1.26],越低越好)。
- CC组71例(90%)完成至少11次访视;作者认为需进一步研究CC在其他医疗环境中的实施与成本效果。
适用人群与场景
- 成人创伤性脑损伤(轻至重度,入组前至少6个月)伴慢性疼痛,于2家医院附属学术康复医学诊所招募。
- 已知TBI严重度的149例中,97例(65%)为轻度TBI。
- 参与者多为女性(92例[58%]),平均(SD)年龄46.8(13.2)岁,平均(SD)受教育年限15.3(3.0)年;TBI发生于入组前平均(SD)4.0(5.9)年(中位数[IQR] 1.9[0.8-4.5]年)。
处置流程与药物剂量
- 协同照护(TBI Care):16周内最多12次面对面或电话访视,由照护管理者提供以人为中心的认知行为治疗。
- 照护管理者每周与专家团队成员会面,回顾参与者并讨论优化治疗的建议。
研究设计与关键结果
- 研究类型:随机临床试验;2018年7月至2021年4月在华盛顿州西雅图2家医院附属学术康复医学诊所开展;数据分析于2022年3月30日至2023年8月30日进行。
- 筛查1379人,随机158例(CC 79例、UC 79例)。
- 主要终点:治疗结束时(随机后4个月)简明疼痛量表疼痛干扰评分,CC组显著低于UC组(均数[SD] 3.46[2.17] vs 5.03[2.28])。
- 8个月时疼痛干扰:CC组3.61[2.22] vs UC组4.68[2.51],差异维持。
- 4个月时疼痛严重度:CC组3.63[1.95] vs UC组4.90[1.96],CC组显著更低。
- 4个月时抑郁症状:CC组8.07[5.34] vs UC组11.31[6.37];焦虑症状:CC组6.20[5.17] vs UC组9.58[6.00],CC组均显著更低。
- 满意度:疼痛治疗CC组2.99[1.23] vs UC组2.52[1.25];临床照护CC组3.28[1.00] vs UC组2.84[1.26];整体医疗CC组3.25[0.88] vs UC组2.82[1.00],CC组均显著更高。
- 整体变化印象评分:CC组2.74[1.02] vs UC组3.47[1.26],CC组显著更低(评分越低印象越好)。
证据类型、等级与局限
- 证据类型:随机临床试验。
- 局限:作者指出需进一步研究CC在其他医疗环境中的实施与成本效果。
对床旁实践的改变
- 对TBI后慢性疼痛成人,协同照护模式(16周内最多12次访视、照护管理者提供认知行为治疗并每周与专家团队讨论)在4个月时降低疼痛干扰并维持至8个月。
- 作者认为需进一步研究CC在其他医疗环境中的实施与成本效果。
指南或共识出处
- ClinicalTrials.gov注册号:NCT03523923。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Chronic pain after traumatic brain injury (TBI) is prevalent and associated with poor outcomes. By providing multidisciplinary care through expert consultation, a collaborative care (CC) treatment approach may reduce pain interference.
OBJECTIVE: To compare CC with usual care (UC) in decreasing pain interference.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from July 2018 through April 2021 at 2 hospital-based academic rehabilitation medicine clinics in Seattle, Washington. Participants included adults with mild-to-severe TBI (at least 6 months before enrollment) and chronic pain. Data analysis was performed from March 30, 2022, to August 30, 2023.
INTERVENTION: The CC intervention (called TBI Care) included up to 12 in-person or telephone visits over 16 weeks with a care manager (CM) who provided person-centered cognitive behavioral treatment. The CM met weekly with members of the expert team to review participants and discuss recommendations to optimize treatment.
MAIN OUTCOMES AND MEASURES: The primary outcome was pain interference on the Brief Pain Inventory at treatment conclusion (4 months after randomization). Secondary outcomes included pain interference at 8 months; pain severity; symptoms of depression, anxiety, and sleep disturbance; pain-related emergency department visits; community participation; and participant satisfaction. Linear mixed-effects regression was used for analysis.
RESULTS: A total of 1379 individuals were screened for eligibility, and 158 were randomized (79 to CC and 79 to UC). The participants were mostly women (92 participants [58%]) with a mean (SD) age of 46.8 (13.2) years and a mean (SD) of 15.3 (3.0) years of education. TBI occurred a mean (SD) of 4.0 (5.9) years (median [IQR], 1.9 [0.8-4.5] years) before enrollment. All TBI severities were included, and of 149 participants for whom TBI severity was known, the majority (97 participants [65%]) had mild TBI. In the CC group, 71 participants (90%) completed at least 11 sessions, and, at 4 months, this group had significantly lower pain interference scores compared with the UC group (mean [SD], 3.46 [2.17] vs 5.03 [2.28]). This difference was maintained at 8 months after randomization, with mean (SD) TBI care pain interference scores of 3.61 (2.22) for CC vs 4.68 (2.51) for UC. At 4 months, there was significantly lower pain severity in the CC group vs UC group (mean [SD] score, 3.63 [1.95] vs 4.90 [1.96]), as well as symptoms of depression (mean [SD] score, 8.07 [5.34] vs 11.31 [6.37]) and anxiety (mean [SD], 6.20 [5.17] vs 9.58 [6.00]). Satisfaction with pain treatment (mean [SD] score, 2.99 [1.23] vs 2.52 [1.25]), clinical care (mean [SD] score, 3.28 [1.00] vs 2.84 [1.26]), and overall health care (mean [SD] score, 3.25 [0.88] vs 2.82 [1.00]) were significantly higher in the CC group vs the UC group; global impression of change was significantly lower in the CC group vs the UC group (mean [SD] score, 2.74 [1.02] vs 3.47 [1.26]) (lower scores denote a better impression of change).
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial of CC compared with UC for patients with TBI, CC was effective at reducing pain interference and was sustained at 8-month follow-up. Further research is needed to examine the implementation and cost-effectiveness of CC for TBI in other health care settings.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03523923.
参考来源
- Hoffman JM, Curran M, Barber J, et al. Collaborative Care for Chronic Pain After Traumatic Brain Injury: A Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 38829619. doi:10.1001/jamanetworkopen.2024.13459
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。